Progress of personalised oncology treatment
22 Oct 2012
Progress of personalised oncology treatment
Role of ECCO in the development of personalised oncology treatment
Advances in advanced renal cell carcinoma from ESMO 2012: Part 1
Advances in advanced renal cell carcinoma from ESMO 2012: Part 3
Advances in advanced renal cell carcinoma from ESMO 2012: Part 2
Advances in advanced metastatic renal cell carcinoma from ESMO 2012
Treating platinum resistant ovarian cancer
Developing technologies for personalised treatment
Nab-paclitaxel and gemcitabine combating pancreatic cancer
Chemotherapy and radiotherapy in advanced local non-small cell lung cancer
Hepatic chemosaturation therapy
Advances in soft tissue sarcoma from ESMO 2012